Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

Ege University

Status: Completed

Conditions: Placenta Previa

Treatments: Diagnostic Test: Vaginal Ultrasonography; Diagnostic Test: Magnetic Resonance Imaging

Study type: Interventional

Funder types: Other

Identifiers

NCT04264234

18-9.1/27

Details and patient eligibility

About

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Enrollment: 98 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Monitoring of placenta previa
• To apply before the 28th week
• To have a low-risk second trimester screening test
• No malformation detected in the anomaly screening

Exclusion criteria

• Multiple pregnancies
• Pregnancy complicated with preeclampsia
• Pregnancy complicated by gestational hypertension
• Pregnancy complicated by gestational diabetes mellitus

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

98 participants in 1 patient group

Placenta Previa

Experimental group

Description:

Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography and MRI.

Treatment:

Diagnostic Test: Magnetic Resonance Imaging

Diagnostic Test: Vaginal Ultrasonography